Close



Mar 28, 2024 08:32AM
Mar 28, 2024 08:30AM
Mar 19, 2024 07:31AM
Mar 19, 2024 07:30AM
Feb 29, 2024 04:05PM
Jan 8, 2024 09:26AM
Jan 8, 2024 09:26AM PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 42nd Annual J.P. Morgan Healthcare Conference
Dec 5, 2023 04:16PM
Dec 5, 2023 04:15PM
Oct 26, 2023 04:05PM
Sep 15, 2023 09:18AM
Aug 3, 2023 04:01PM
Jul 21, 2023 09:30AM
Jul 21, 2023 09:30AM CHMP Recommends Evrysdi® for Babies Under Two Months Old with Spinal Muscular Atrophy
Apr 27, 2023 04:01PM
Jan 9, 2023 09:17AM
Jan 9, 2023 09:15AM
Dec 14, 2022 03:25AM
Oct 27, 2022 04:03PM
Oct 18, 2022 04:02PM
Oct 18, 2022 04:01PM PTC Provides Update on Ongoing Global PIVOT-HD Trial For PTC518
Aug 4, 2022 04:01PM
Jun 21, 2022 04:12PM
Jun 21, 2022 02:37PM
Jun 21, 2022 11:34AM
Jun 3, 2022 08:00AM
May 31, 2022 05:56AM
May 31, 2022 01:00AM FDA Approves Label Extension for Evrysdi® for Infants with Spinal Muscular Atrophy Under 2 Months Old
May 3, 2022 04:01PM
Feb 22, 2022 04:01PM
Jan 25, 2022 05:50AM
Jan 25, 2022 01:00AM
Jan 10, 2022 07:24AM
Jan 10, 2022 07:00AM
Sep 29, 2021 08:00AM Results Show Long-Lasting and Holistic Improvements in Children with AADC Deficiency Treated with PTC-AADC Gene Therapy
Sep 13, 2021 08:00AM
Jul 29, 2021 04:00PM
Jun 24, 2021 08:00AM
Jun 23, 2021 08:07AM
Jun 23, 2021 08:00AM
Jun 11, 2021 01:00AM
May 26, 2021 08:11AM PTC Therapeutics (PTCT) Announces Orphan Drug Designations of PTC923 for the Treatment of Hyperphenylalaninemia
May 26, 2021 08:00AM
May 4, 2021 04:01PM
Apr 1, 2021 08:00AM
Mar 16, 2021 06:21AM
Mar 16, 2021 02:00AM
Mar 15, 2021 08:00AM
Mar 9, 2021 08:00AM Spinal Muscular Atrophy (SMA) Foundation and PTC Therapeutics Expand Partnership to Advance Drug Discovery and Development Research in Regenerative Medicine
Feb 26, 2021 06:42AM

251,863 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All